A significant number of protein kinase inhibitors was developed, and it can be said that they caused a revolution in oncology and hematology over the last 20 years; however, save for several cases of chronic myeloid leukemia, no one patient was cured with only monotherapy [26,27,28]. This evidence concerns the gene WEE1 and chronic myelogenous leukemia, BCR-ABL1 positive.